“…EB-1 is an anti-inflammatory antioxidant compound that is under investigation for reperfusion injury ( Aras et al, 2014 ), stroke ( Yamaguchi et al, 1998 ), hearing loss ( Kil et al, 2021 ) and bipolar disorder ( Singh et al, 2013 ). Previous research in our lab has shown the edema-reducing and anti-vesicant ( Lulla et al, 2014 ), anti-bacterial ( Chan et al, 2007 ), anti-fungal ( Billack et al, 2010 , Orie et al, 2017 ) and cyto-protective ( Hardej and Billack, 2007 , Pino and Billack, 2008 , Pino et al, 2013 ) properties of EB-1. The second compound tested here was HC, a corticosteroid with immunosuppressant activity (Issekutz, 1983, Coutinho and Chapman, 2011 ), is used topically in the treatment of various inflammatory skin conditions such as allergic rashes, eczema and psoriasis.…”